Linklaters advises QIAGEN on the successful placement of US$750 million convertible bond

Linklaters advised QIAGEN N.V. on the successful placement of convertible bonds with a total nominal amount of US$750 million. The bonds with maturity in 2032 bear interest at a rate of 2.0 per cent per annum and may be converted into ordinary shares of QIAGEN. Application has been made for the bonds to be admitted to trading on the Open Market (Freiverkehr) segment of the Frankfurt Stock Exchange.

The net proceeds will be used for general corporate purposes, including the refinancing of existing liabilities.

The Linklaters team was led by Alexander Schlee (Partner, Capital Markets, Frankfurt) and also included Catrin Retzmann (Associate, Capital Markets, Frankfurt).

Linklaters regularly advises companies and investment banks on the placement of exchangeable bonds and convertible bonds. Over the past 12 months, the Capital Markets team led by Alexander Schlee advised the real estate groups Vonovia SE, TAG Immobilien AG and LEG Immobilien SE, among others, on the issuance of convertible bonds as well as the banking syndicate on the placement of convertible bonds by RedCare Pharmacy N.V. and Deutsche Lufthansa AG.